查詢結果分析
來源資料
相關文獻
- 簡易製備細胞凋亡藥物碘-123-annexin V
- 鎝氧環丁基丙烯氨圬非鏡像立體異構物作為局部腦血流腦灌注造影劑之動物實驗評估
- High Extracerebral Soft Tissue Activity on [fee6]Tc-ECD Brain SPECT Secondary to Radiopharmaceutical Fault
- Effect of Temperature on Radiochemical Purity and Immunoreactivity of Radiolabeled Monoclonal Antibody 1H10
- Stabilities of 阷TcO-CB-PAO Diastereoisomers in Dilute Aqueous Solutions
- 銦-111-DTPA -Octreotide之放射化學純度分析方法比較與金屬離子含量對於銦-111-DTPA -Octreotide之標幟效率影響研究
頁籤選單縮合
題名 | 簡易製備細胞凋亡藥物碘-123-annexin V=A Feasible Method to Prepare 123I-Annexin V for Imaging Apoptosis |
---|---|
作者姓名(中文) | 廖美秀; 詹東榮; 魏孝萍; 江昭志; 戚謹文; 傳應凱; 沈立漢; | 書刊名 | 核子醫學雜誌 |
卷期 | 19:4 民95.12 |
頁次 | 頁231-238 |
分類號 | 418.346 |
關鍵詞 | 碘-123-annexin V; 超離心純化法; 放射化學純度; 123I-annexin V; Ultracentrifugation; Radiochemical purity; |
語文 | 中文(Chinese) |
中文摘要 | 背景:藉由annexin V與phosphatidylserine (PS)的特異性結合能力而發展的放射性標幟annexin V可用於觀測細胞凋亡(apoptosis)時的PS細胞膜外表現。許多放射性標幟annexin V使用雙官能基(土方攵虫)合劑修飾annexin V,需要毫克量價格昂貴的annexin V。本研究評估以碘-123標幟微量annexin V合併使用超離心(ultracentrifugation)技術純化標幟物製備碘-123-anncxin V之可行性。 方法:置10µg annexin V、40µ1 0.1M磷酸二氫鉀溶液及1~10 mCi碘-123-碘化銨於一塗佈50µg Iodo-Gen之試管內,室溫下反應10分鐘,再以Nanosep(上標 TM)分離管進行超離心純化。以ITLC-SG放射薄層色層分析法(分別以0.9%氣化鈉溶液及85%乙醇溶液展開)以及Ultrahydrogel 250放射FPLC(流動相為pH 7.4之0.01 M磷酸二氫鉀溶液,流速為每分鐘0.8 ml)進行放射化學純度量測及標幟產率分析。以sodium dodecyl sulphate-polyacrylamide凝膠電泳(SDS-PAGE)(gel electrophoresis)確認碘-123-annexin V分子大小。以試管試驗分析碘-123-annexin V是否仍保有對PS的特異結合能力。 結果:六次標幟實驗結果顯示以碘-123-碘化銨進行碘化反應的標幟效率為59~87%。以Nanosep(上標 TM)超離心純化後之碘-123-annexin V放射化學純度均大於90%,且具有至少48小時之安定性。SDS-PAGE分析碘-123-annexin V分子量與人類annexin V(35.8kDa)相當。碘-123-annexin V放射活性滯留在含PS之試管明顯高於不含PS之對照組(P<0.03),顯示碘-123-annexin V仍保有對PS的特異結合能力。 結論:使用微量annexin V及Iodo-Gen氧化性碘化反應,並合併使用Nanosep(上標 TM)超離心法純化標幟物,可以快速製備高穩定性及具PS結合能力的碘-123-annexin V。 |
英文摘要 | Background: The exposure of phosphatidylserine (PS) on the cell surface is one of the early stages in apoptotic cells. Annexin V is a protein with a high affinity for PS, therefore, annexin V-mediated detection of PS becomes more important for monitoring cells under apoptosis. Many annexin Vbased radiotracers have been developed by conjugation of annexin V with various bifunction chelators. However, the conjugation required several mg of very expensive recombinant human annexin V. This study evaluated a feasible method that prepared 123I-annexin V by using μg-level protein for oxidative radioiodination and followed by ultracentrifugation for purification. Methods: Radioiodination was carried out for 10 min at room temperature by mixing 10 μg of annexin V, 1~10mCi of 123I-ammonium iodide and 40μl of 0.1M KH2PO4 in a test tube precoated with 50mg of Iodo-Gen. The radioiodinated annexin V was purified by Nanosep(superscript TM) ultracentrifugation, and its radiochemical purity was determined by radio-instant thin layer chromatography (ITLC) and fast protein liquid chromatography (FPLC), respectively. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was used to determine the molecular size of 123Iannexin V. The specific binding of the radiotracer for PS was verified by incubating and counting 123I-annexin V in the test tubes with and without PS. Results: The radiolabeling yield ranges 59~87% for six preparations. Following purification with Nanosep(superscript TM) ultracentrifugation, the radiochemical purity of 123I-annexin V was more than 90%. The in-vitro stability of 123I-annexin V was verified for up to 48h. The result of SDS-PAGE revealed that the molecular weight of the radiotracer was similar to that of human annexin V (35.8kDa). The significant retention of radioactivity in PS-containing test tubes than those in PS-free control (P<0.03) demonstrated the specific biding capability of 123I-annexin V for PS. Conclusions: By using μg-level annexin V for oxidative radioiodination and followed by employing ultracentrifugation for purification, 123I-annexin V can be rapidly prepared in high radiochemical purity, with high stability and capability to bind PS specifically. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。